Volitionrx (VNRX) Amortization of Deferred Charges (2021 - 2025)
Volitionrx (VNRX) posted Amortization of Deferred Charges of $49741.0 for Q4 2025, down 18.15% on a QoQ basis from $60774.0 in Q3 2025, and down 11.92% year-over-year from $56475.0 in Q4 2024.
Volitionrx (VNRX) Amortization of Deferred Charges (2021 - 2025) Analysis & Trends
Volitionrx's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $49741.0 for Q4 2025.
- Quarterly Amortization of Deferred Charges fell 11.92% year-over-year to $49741.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $232695.0 (up 3.08% YoY) and the FY2025 annual result came in at $232695.0, up 3.08% from the prior year.
- Amortization of Deferred Charges was $49741.0 for Q4 2025 at Volitionrx, down from $60774.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $67899.0 in Q2 2022 and bottomed at $49040.0 in Q3 2021.
- A 5-year average of $59656.0 and a median of $60302.0 in 2022 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2022 — Amortization of Deferred Charges climbed 22.72% — and 2024, when it declined 16.18%.
- Volitionrx's Amortization of Deferred Charges stood at $51718.0 in 2021, then increased by 16.83% to $60420.0 in 2022, then climbed by 10.41% to $66707.0 in 2023, then declined by 15.34% to $56475.0 in 2024, then retreated by 11.92% to $49741.0 in 2025.
- Business Quant data shows VNRX's Amortization of Deferred Charges at $49741.0 in Q4 2025, $60774.0 in Q3 2025, and $65855.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49,741.00 |
| Dec 31, 2025 | 49,741.00 |
| Sep 30, 2025 | 60,774.00 |
| Sep 30, 2025 | 60,774.00 |
| Jun 30, 2025 | 65,855.00 |
| Jun 30, 2025 | 65,855.00 |
| Mar 31, 2025 | 56,325.00 |
| Mar 31, 2025 | 56,325.00 |
| Dec 31, 2024 | 56,475.00 |
| Dec 31, 2024 | 56,475.00 |
| Sep 30, 2024 | 56,239.00 |
| Sep 30, 2024 | 56,239.00 |
| Jun 30, 2024 | 54,168.00 |
| Jun 30, 2024 | 54,168.00 |
| Mar 31, 2024 | 58,866.00 |
| Mar 31, 2024 | 58,866.00 |
| Dec 31, 2023 | 66,707.00 |
| Dec 31, 2023 | 66,707.00 |
| Sep 30, 2023 | 66,826.00 |
| Sep 30, 2023 | 66,826.00 |